Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Prestige Consumer Healthcare Inc

PBH ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Pharmaceuticals ·

USA Mid Cap Analyst: BUY

Last Close

$51.38

▲ +0.12%

Market Cap $2.43B · Vol 120.15K

Key Metrics

P/E Ratio

14.39

FWD: 10.80

Market Cap

$2.43B

Mid Cap

Div Yield

N/A

EPS Growth

+4.60%

YoY

RSI (14)

53.57

Momentum

Beta

0.33

vs Market

52W High

$70.97

27.60% below

52W Low

$42.66

20.44% above

Volume

120.15K

Avg 163.09K

P/B

1.49

Price-to-book

ROE

11.46%

Return on equity

Free Float

98.56%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Prestige Consumer Healthcare Inc (PBH) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PBH pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.33%

+8.88%

+11.87%

-23.07%

YTD

-16.71%

-20.46%

-18.05%

-14.09%

Financials & Valuation

TTM · Annual

Total Revenue	$1.09B
Net Income	$190.30M
Revenue Growth (YoY)	+6.48%
Gross Margin	52.78%
Operating Margin	28.42%
Net Profit Margin	17.48%
ROE	11.46%
ROA · ROIC	7.47% · 7.70%

P/E Ratio	14.39
Forward P/E (FY1)	10.80
PEG Ratio	-1.71
P/S	2.65
P/B	1.49
P/FCF	11.72
EPS Growth	+4.60%
Outstanding Shares	47.37M

Technical Indicators

50-Day SMA	$49.36
200-Day SMA	$57.45
RSI (14)	53.57
Beta	0.33
52-Week High	$70.97
52-Week Low	$42.66

Volume Today	120.15K
Avg Daily Volume (30D)	163.09K
Relative Volume	0.74x
Volatility (10D)	33.42
Volatility (30D)	35.99
Free Float	98.56%

Analyst Consensus

BUY

Current Price $51.38

Mean Target $67.25

52W Low$42.66 52W High$70.97

Current

Target

$42.66 $70.97

Current Analyst target

+30.89% upside potential · 8 analysts

Identifiers

ExchangeNYSE

FIGIBBG001SH44F0

ISINUS74112D1019

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Prestige Consumer Healthcare Inc. develops, manufactures, markets, sells and distributes over-the-counter (OTC) health and personal care products to mass merchandisers, drug/drug wholesale, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Breathe Right nasal strips, Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.